![Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review | Journal of the American College of Cardiology Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/7d5f7519-c575-41f0-8c18-dcf92e6f4c2e/fx1.jpg)
Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management | Canadian Journal of Neurological Sciences | Cambridge Core Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management | Canadian Journal of Neurological Sciences | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20211227021212176-0240:S0317167121000342:S0317167121000342_tab3.png?pub-status=live)
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management | Canadian Journal of Neurological Sciences | Cambridge Core
![Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12955-020-01600-z/MediaObjects/12955_2020_1600_Fig1_HTML.png)
Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study | Health and Quality of Life Outcomes | Full Text
![JCM | Free Full-Text | Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry JCM | Free Full-Text | Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry](https://www.mdpi.com/jcm/jcm-09-01698/article_deploy/html/images/jcm-09-01698-g001.png)
JCM | Free Full-Text | Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
![ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable | Orphanet Journal of Rare Diseases | Full Text ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-021-01834-0/MediaObjects/13023_2021_1834_Fig1_HTML.png)
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable | Orphanet Journal of Rare Diseases | Full Text
![Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy - ScienceDirect Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719339208-fx1.jpg)